Applications of Encapsulation and Controlled Release [electronic resource].
Material type:
TextSeries: Publisher: Milton : CRC Press LLC, 2019Edition: 2nd edDescription: 1 online resource (491 p.)ISBN: 9781000566925; 1000566927; 9780429299520; 0429299524; 9781000571783; 1000571785; 9781000576641; 1000576647Subject(s): MEDICAL / Biotechnology | SCIENCE / Chemistry / General | TECHNOLOGY / Material Science | Controlled release technology | Drug delivery systemsDDC classification: 660/.28 LOC classification: TP156.C64 | A67 2019Online resources: Taylor & Francis | OCLC metadata license agreement Description based upon print version of record.
Cover; Half Title; Series Page; Title Page; Copyright Page; Dedication Page; Contents; Preface; Editor; Contributors; 1: Multi-Cyclodextrin Supramolecular Encapsulation Entities for Multifaceted Topical Drug Delivery Applications; 1.1 Introduction; 1.2 Cyclodextrin Properties That Confer Suitability in Drug Delivery Applications; 1.3 Types of Multi-Cyclodextrin Entities: Properties and Applications; 1.3.1 Cyclodextrin-Based Polyrotaxanes; 1.3.2 Cyclodextrin-Based Nanosponges; 1.3.3 Cyclodextrin Polymers; 1.4 Approaches to the Production of Cyclodextrins: Synthesis and Derivatives
1.4.1 Cyclodextrin-Based Polyrotaxanes1.4.1.1 Threading Process; 1.4.1.2 Rotaxanation of Pseudopolyrotaxanes; 1.4.2 Cyclodextrin-Based Nanosponges; 1.5 Cyclodextrins and Multi-Cyclodextrins Applied for Topical and Targeted Drug Delivery; 1.5.1 Tissue Surface Applications; 1.5.1.1 Ocular Surface Applications; 1.5.1.2 Oral Cavity and Tooth Surface Applications; 1.5.1.3 Dermal Applications; 1.5.2 Mucosal Membrane Applications; 1.5.2.1 Buccal Mucosa; 1.5.2.2 Sublingual Mucosa; 1.5.2.3 Nasal Mucosa; 1.6 Conclusion; Conflict of Interest; Acknowledgments; References
2: Nanocomplexes for Topical Drug Delivery2.1 Introduction; 2.2 Skin Morphology and Barrier Functions; 2.3 Purpose of Topical Preparation; 2.4 Nanotechnology for the Skin; 2.5 Different Nanocarriers for Topical Delivery; 2.5.1 Nanoparticles; 2.5.2 Nanoemulsions; 2.5.3 Solid Lipid Nanoparticles (SLNs); 2.5.4 Nanostructured Lipid Carriers (NLCs); 2.5.5 Liposomes; 2.5.6 Niosomes; 2.5.7 Dendrimers; 2.6 Delivery of Drugs through Nanocarriers; 2.6.1 Anti-Inflammatory Drugs; 2.6.2 Anti-Photoaging Drugs and Antioxidants; 2.6.3 Antimicrobial Agents; 2.6.4 Anti-Proliferative Agents; 2.7 Conclusion
3.5.3 Initiator Employed for Hydrogels3.5.4 Cross-linkers Employed for Preparation of Hydrogels; 3.5.5 Applications; 3.5.6 Subcutaneous Drug Targeting; 3.5.7 Transdermal Delivery; 3.5.8 Delivery of Growth Factors; 3.5.9 Cancer; 3.5.10 Wound Dressing; 3.5.11 Oral Treatment; 3.5.12 Ophthalmic Delivery; 3.5.13 GIT Targeting; 3.6 Conclusion; References; 4: Polymer-Drug Conjugates as Drug Delivery Systems; 4.1 Introduction; 4.2 Self-Assembly Behavior of Amphiphilic Polymer-Drug Conjugates; 4.3 Self-Assembled Polymer-Drug Conjugates; 4.4 Stimuli-Responsive Self-Assembled Polymer-Drug Conjugates
4.5 pH-Responsive Self-Assembled Polymer-Drug Conjugates
The field of encapsulation, especially microencapsulation, is a rapidly growing area of research and product development. Applications of Encapsulation and Controlled Release offers a broad perspective on a variety of applications and processes, including, up-to-date research, figures, tables, illustrations, and references. Written at a level comprehensible to non-experts, it is a rich source of technical information and current practices in research and industry.
OCLC-licensed vendor bibliographic record.